| Primary |
| Hypertension |
34.8% |
| Cardiac Failure |
17.1% |
| Cardiac Failure Chronic |
9.1% |
| Cardiovascular Disorder |
8.4% |
| Diabetes Mellitus |
7.2% |
| Coronary Artery Disease |
3.1% |
| Type 2 Diabetes Mellitus |
2.6% |
| Hyperlipidaemia |
2.2% |
| Prophylaxis |
2.1% |
| Hyperuricaemia |
2.1% |
| Atrial Fibrillation |
2.0% |
| Cardiac Failure Congestive |
1.7% |
| Thrombosis Prophylaxis |
1.5% |
| Cardiac Failure Acute |
1.0% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Gastritis Prophylaxis |
0.9% |
| Hypercholesterolaemia |
0.9% |
| Insomnia |
0.8% |
| Benign Prostatic Hyperplasia |
0.8% |
| Nephrotic Syndrome |
0.8% |
|
| Death |
15.1% |
| Cardiac Failure |
10.2% |
| Renal Impairment |
9.9% |
| Urine Albumin/creatinine Ratio Increased |
7.7% |
| Renal Failure |
5.1% |
| Syncope |
4.8% |
| Renal Failure Chronic |
4.5% |
| Hyponatraemia |
3.7% |
| Renal Failure Acute |
3.7% |
| Vomiting |
3.7% |
| Weight Decreased |
3.7% |
| Coronary Artery Disease |
3.4% |
| Glycosylated Haemoglobin Increased |
3.4% |
| Blood Creatinine Increased |
3.1% |
| Blood Pressure Increased |
3.1% |
| Dyspnoea |
3.1% |
| Hyperkalaemia |
3.1% |
| Sudden Cardiac Death |
3.1% |
| Glomerular Filtration Rate Decreased |
2.8% |
| Angina Pectoris |
2.6% |
|
| Secondary |
| Cardiac Failure |
45.2% |
| Hypertension |
13.3% |
| Cardiac Failure Chronic |
8.4% |
| Diabetes Mellitus |
4.1% |
| Coronary Artery Disease |
3.6% |
| Cardiovascular Disorder |
3.4% |
| Cardiac Failure Congestive |
3.0% |
| Hyperuricaemia |
2.7% |
| Prophylaxis |
2.6% |
| Type 2 Diabetes Mellitus |
2.3% |
| Atrial Fibrillation |
1.8% |
| Insomnia |
1.5% |
| Hyperlipidaemia |
1.4% |
| Glaucoma |
1.3% |
| Thrombosis Prophylaxis |
1.1% |
| Myocardial Infarction |
1.1% |
| Renal Failure Chronic |
0.8% |
| Dyslipidaemia |
0.8% |
| Hypokalaemia |
0.8% |
| Product Used For Unknown Indication |
0.8% |
|
| Renal Impairment |
10.2% |
| Vomiting |
9.2% |
| Dyspnoea |
7.6% |
| Prostate Cancer |
6.7% |
| Cardiac Failure |
6.1% |
| Concomitant Disease Progression |
5.4% |
| Hypotension |
5.1% |
| Syncope |
5.1% |
| Vertigo |
5.1% |
| Weight Increased |
4.8% |
| Disease Progression |
4.1% |
| Renal Failure |
4.1% |
| Pulmonary Oedema |
3.8% |
| Asthma |
3.5% |
| Condition Aggravated |
3.5% |
| Ventricular Tachycardia |
3.5% |
| Death |
3.2% |
| Urinary Tract Infection |
3.2% |
| General Physical Health Deterioration |
2.9% |
| Hyperkalaemia |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
30.3% |
| Hypertension |
19.7% |
| Product Used For Unknown Indication |
18.7% |
| Diabetes Mellitus |
4.1% |
| Blood Pressure |
3.4% |
| Pain |
3.0% |
| Atrial Fibrillation |
2.6% |
| Rheumatoid Arthritis |
2.4% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Blood Cholesterol Increased |
1.5% |
| Arthritis |
1.5% |
| Chronic Sinusitis |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Prostate Cancer Metastatic |
1.3% |
| Supplementation Therapy |
1.3% |
| Asthma |
1.2% |
| Depression |
1.2% |
| Cardiac Disorder |
1.1% |
| Glioblastoma |
1.1% |
| Hyperlipidaemia |
1.1% |
|
| Renal Failure |
10.8% |
| Rhabdomyolysis |
7.5% |
| Drug Ineffective |
5.8% |
| Pneumonia |
5.8% |
| Weight Decreased |
5.8% |
| Weight Increased |
5.8% |
| Blood Glucose Increased |
5.0% |
| Hyperkalaemia |
5.0% |
| Pruritus |
5.0% |
| Thrombocytopenia |
5.0% |
| Cardiac Failure Acute |
4.2% |
| Death |
4.2% |
| Dyspnoea |
4.2% |
| Hypotension |
4.2% |
| Stevens-johnson Syndrome |
4.2% |
| Suicide Attempt |
4.2% |
| Cardiac Failure |
3.3% |
| Cerebrovascular Accident |
3.3% |
| Dizziness |
3.3% |
| Myalgia |
3.3% |
|
| Interacting |
| Hypertension |
73.3% |
| Otitis Media Acute |
10.0% |
| Pain |
6.7% |
| Cardiac Failure Chronic |
3.3% |
| Infection |
3.3% |
| Product Used For Unknown Indication |
3.3% |
|
| Nausea |
33.3% |
| Peripheral Coldness |
33.3% |
| Electrocardiogram Qrs Complex Prolonged |
11.1% |
| Heart Rate Increased |
11.1% |
| Tachycardia |
11.1% |
|
